Multivalent Molecular Imaging and Therapy for Novel Applications

Publication ID: 24-11857648_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Multivalent Molecular Imaging and Therapy for Novel Applications,” Published Technical Disclosure No. 24-11857648_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857648_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,648.

Summary of the Inventive Concept

This inventive concept leverages the core technology of multivalent molecular imaging and therapy to address pressing needs in water quality monitoring, food safety, neurological disorder diagnosis, environmental pollutant detection, and agricultural product biomarker detection.

Background and Problem Solved

The original patent's multivalent molecular imaging and therapy approach has shown promise in various biomedical applications. However, its potential extends beyond the original scope. This inventive concept tackles the limitations of current methods in diverse fields, where the ability to target multiple biomarkers with a single molecule can revolutionize detection, diagnosis, and monitoring.

Detailed Description of the Inventive Concept

The new claims introduce the application of multivalent molecular imaging and therapy to novel fields, including water quality monitoring, food safety, neurological disorder diagnosis, environmental pollutant detection, and agricultural product biomarker detection. These claims describe systems, methods, and kits that utilize the core technology to target specific biomarkers associated with waterborne pathogens, contaminants in food products, neurological disorders, environmental pollutants, and agricultural products. The multivalent molecules carry detectable labels, enabling the detection and monitoring of these biomarkers.

Novelty and Inventive Step

The novelty of this inventive concept lies in the unexpected application of the original patent's multivalent molecular imaging and therapy approach to entirely new industries and problems. The inventive step is the recognition of the potential for this technology to be adapted and modified to address the specific needs of these novel fields.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include the use of different types of detectable labels, varying the structure and composition of the multivalent molecules, or integrating the technology with existing detection systems. Variations could also involve adapting the technology for use in other fields, such as veterinary medicine or biodefense.

Potential Commercial Applications and Market

The commercial potential of this inventive concept is significant, with applications in water quality monitoring, food safety, neurological disorder diagnosis, environmental pollutant detection, and agricultural product biomarker detection. The target industries include environmental monitoring, food processing, pharmaceuticals, and agriculture, with potential market sizes in the billions of dollars.

CPC Classifications

SectionClassGroup
A A61 A61K51/082
A A61 A61K9/51
A A61 A61K47/6893
A A61 A61K51/1027
C C07 C07D255/02
C C07 C07D257/02
C C07 C07K7/06
C C07 C07K7/64
C C07 C07K16/30
G G01 G01N33/5008
G G01 G01N33/60
C C07 C07K2319/00

Original Patent Information

Patent NumberUS 11,857,648
TitleDimerization strategies and compounds for molecular imaging and/or radioimmunotherapy
Assignee(s)UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION